172 related articles for article (PubMed ID: 18657193)
1. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases.
Kawasaki T; Nakamura S; Sakamoto G; Murata S; Tsunoda-Shimizu H; Suzuki K; Takahashi O; Nakazawa T; Kondo T; Katoh R
Histopathology; 2008 Sep; 53(3):288-98. PubMed ID: 18657193
[TBL] [Abstract][Full Text] [Related]
2. Synchronous bilateral neuroendocrine ductal carcinoma in situ.
Honami H; Sotome K; Sakamoto G; Iri H; Tanaka Y; Fukamachi S; Morozumi K
Breast Cancer; 2014 Jul; 21(4):508-13. PubMed ID: 21735237
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].
Yang WT; Xu YX; Zhang TQ
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):594-7. PubMed ID: 17134566
[TBL] [Abstract][Full Text] [Related]
4. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine ductal carcinoma in situ of the breast: cytological features in 32 cases.
Kawasaki T; Nakamura S; Sakamoto G; Kondo T; Tsunoda-Shimizu H; Ishii Y; Nakazawa T; Mochizuki K; Yamane T; Inoue M; Inoue S; Katoh R
Cytopathology; 2011 Feb; 22(1):43-9. PubMed ID: 20236292
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Synchronous Bilateral Neuroendocrine Ductal Carcinoma In Situ].
Hoshi N; Abe N; Tachibana K; Noda M; Murakami Y; Okano M; Yoshida S; Abe S; Kiko Y; Hashimoto Y; Ohtake T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2222-2224. PubMed ID: 32156885
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of neuroendocrine carcinoma in breast lesions detected by the clinical symptom of bloody nipple discharge.
Kawasaki T; Mochizuki K; Yamauchi H; Yagata H; Kondo T; Tsunoda H; Nakamura S; Oishi N; Nakazawa T; Yamane T; Inoue A; Maruyama T; Inoue M; Inoue S; Fujii H; Katoh R
Breast; 2012 Oct; 21(5):652-6. PubMed ID: 22397895
[TBL] [Abstract][Full Text] [Related]
8. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.
Abe E; Suzuki K; Hayashi N; Yang Y; Li CP; Uno M; Akiyama F; Yamauchi H; Nakamura S; Tsugawa K; Tsunoda H; Ohde S; Sasano H
Pathol Int; 2014 Feb; 64(2):58-66. PubMed ID: 24629173
[TBL] [Abstract][Full Text] [Related]
11. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
[TBL] [Abstract][Full Text] [Related]
12. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
13. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
Kelten Talu C; Savli TC; Huq GE; Leblebici C
Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
[TBL] [Abstract][Full Text] [Related]
14. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
15. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
17. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
Rudnicka L; Stachura J
Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
[TBL] [Abstract][Full Text] [Related]
18. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
Park K; Han S; Kim HJ; Kim J; Shin E
Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686
[TBL] [Abstract][Full Text] [Related]
19. Management of Neuroendocrine Ductal Carcinoma In Situ of the Breast.
Ma BL; Rooks CO; Christopher WO; Berry SM
Am Surg; 2023 Aug; 89(8):3526-3527. PubMed ID: 36866802
[TBL] [Abstract][Full Text] [Related]
20. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
